- The leading innovative plug-and-play ultrasonic shears with integrated transducer designed for open surgery
SINGAPORE, June 3, 2026 /PRNewswire/ -- Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears designed for open surgical procedures, including breast and thyroid surgeries.
SOUND REACH Swift features a plug-and-play, single-unit innovative design that integrates a customised, lightweight power transducer with a fine curved-tip blade, enabling efficient and consistent ultrasonic energy delivery. This supports reliable coagulation for vessels up to 5 mm and precise dissection in confined anatomy, while simplifying preoperative preparation by eliminating conventional handpiece assembly and separate handpiece management and sterilisation.
Featuring a forceps-style design based on instruments commonly used in open surgery, SOUND REACH Swift enables tissue grasping, dissection and coagulation within a single device, reducing the need for instrument exchanges. Its compact, lightweight design improves hand manoeuvrability and helps reduce surgeon fatigue during prolonged procedures.
Together, these features support ease of use and workflow efficiency during open surgery, particularly in thyroid and breast surgeries performed within confined anatomical spaces and near critical structures. In these settings, controlled energy delivery and effective thermal management are essential. SOUND REACH Swift has been designed to meet these procedural requirements and challenges.
In thyroid and breast surgeries, demand continues to grow with rising global disease burden. GLOBOCAN 2022 estimates 2.3 million new breast cancer cases and approximately 821,000 thyroid cancer cases globally. This rising trend drives greater focus on technologies that support tissue protection, reduce procedural complexity, and deliver consistent performance in the operating theatre.
SOUND REACH Swift expands Reach Surgical's energy portfolio into open surgery, complementing its ultrasonic and advanced bipolar technologies available on the ENER REACH OP9 platform, which supports both energy modalities within a single system.
Regulatory Notice: SOUND REACHTM Swift is a registered trademark of Reach Surgical. Product availability is subject to local regulatory approvals.
About Genesis MedTech Group
Genesis MedTech Group is a global medical device company headquartered in Singapore, dedicated to Making Better Healthcare Happen. We design and develop medical technologies that make treatments less invasive and more accessible at scale, supporting healthcare providers in delivering quality care and enabling more patients to benefit from medical advances. With integrated capabilities from R&D and manufacturing to commercialisation, Genesis MedTech builds on a strong foundation of quality, training and education, serving surgical, cardiology, and vascular interventional specialties.
Reach Surgical, the surgical solutions division of Genesis MedTech, provides a comprehensive surgical portfolio designed to support surgeons and advance surgical care. Through product development, clinical education and collaboration with surgeons, Reach Surgical is committed to addressing the evolving needs of modern surgery.
Learn more at https://www.genesismedtech.com and follow us on LinkedIn.
Photo - https://mma.prnewswire.com/media/2990316/Swift_Picture.jpg
Logo - https://mma.prnewswire.com/media/2792720/Reach_Logo_2024_Color_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reach-surgical-receives-ce-mark-approval-for-sound-reach-swift-302786325.html
